Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Simplification to Dolutegravir + Darunavir/Cobicistat in Suppressed HIV-1
NCT03683524Phase 4Completed
- Start
- Nov 2018
- Primary completion
- Aug 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of dolutegravir, darunavir, cobicistat in human immunodeficiency virus type 1 infection (HIV-1). Started Nov 2018; status: completed.
02
Drugs
dolutegravirdarunavircobicistat
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT03683524.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03683524.